[Acute bronchiolitis, an updated review]

Area of Science:

• Pediatrics
• Virology
• Infectious Diseases

Context:

• Acute bronchiolitis (AB) is a common pediatric hospitalization cause, particularly during fall and winter.
• Respiratory syncytial virus (RSV) is the primary etiological agent.
• High-risk pediatric populations (e.g., premature infants, those with chronic conditions) face elevated morbidity and mortality.

Purpose:

• To review the epidemiology, pathophysiology, treatment, and prophylaxis of acute bronchiolitis.
• To highlight the challenges in definitive treatment and the importance of supportive care.
• To underscore the generally favorable prognosis for most children while acknowledging prolonged recovery in some.

Summary:

• RSV infection leads to inflammation and airway obstruction in children, causing symptoms like wheezing and gas exchange imbalance.
• Current management involves supportive care, including oxygen therapy and hydration, with limited definitive treatment options.
• Prophylaxis with monoclonal antibodies is available, and most children recover without long-term sequelae, though recovery duration varies.

Impact:

• Informs healthcare providers about the clinical course and management strategies for acute bronchiolitis.
• Emphasizes the need for continued research into effective treatments for RSV-induced AB.
• Guides public health awareness regarding seasonal respiratory infections in children.